This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
MA Battista , R Hierholzer , HR Khonzam , A Barlow , (2007). Pilot trial of memantine in the treatment of posttraumatic stress disorder. Psychiatry 70, 167–174.
V Bergink , HJGM van Megen , HGM Westenberg (2004). Glutamate and anxiety. European Neuropsychopharmacology 14, 175–183.
DD Blake , FW Weathers , LM Nagy , DG Kaloupek , (1995). The development of a clinician-administered PTSD scale. Journal of Traumatic Stress 8, 75–90.
M Davis , KM Myers (2002). The role of glutamate and gamma-aminobutyric acid in fear extinction: clinical implications for exposure therapy. Biological Psychiatry 52, 998–1007.
R Depoortère , G Dargazanli , G Estenne-Bouhtou , A Coste , (2005). Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-lSSR504734, a potential new type of antipsychotic. Neuropsychopharmacology 30, 1965–1985.
S File , E Fluck , C Fernandes (1999). Beneficial effects of glycine (bioglycine) on memory and attention in young and middle-aged adults. Journal of Clinical Psychopharmacology 19, 505–512.
U Heresco-Levy (2005). Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia. Expert Opinion on Emerging Drugs 10, 827–844.
U Heresco-Levy , DC Javitt , R Ebstein , A Vass , (2005). D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biological Psychiatry 57, 577–585.
U Heresco-Levy , I Kremer , DC Javitt , R Goichman , (2002). Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder. International Journal of Neuropsychopharmacology 5, 301–307.
MD Horner , MB Hamner (2002). Neurocognitive functioning in posttraumatic stress disorder. Neuropsychology Review 12, 15–30.
SA Lipton (2007). Pathologically-activated thrapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. Current Drug Targets 8, 621–632.
AJ McDonald (1996). Glutamate and aspartate immunoreactive neurons of the rat basolateral amygdala: colocalization of excitatory amino acids and projections to the limbic circuit. Journal of Comparative Neurology 365, 367–379.
BS McEwen (1996). Gonadal and adrenal steroids regulate neurochimical and structural plasticity of the hippocampus via cellular mechanisms involving NMDA receptors. Cellular and Molecular Neurobiology 16, 103–116.
BS McEwen (2001). Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Annals of the New York Academy of Sciences 933, 265–277.
JW Newcomer , JH Krystal (2001). NMDA receptor regulation of memory and behavior in humans. Hippocampus 11, 529–542.
MM Norberg , JH Krystal , DF Tolin (2008). A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy. Biological Psychiatry 63, 1118–1126.
BL Schwartz , S Hashtroudi , RL Herting , P Schwartz , (1996). D-cycloserine enhances implicit memory in Alzheimer patients. Neurology 46, 420–424.
M Shleper , E Kartvelishvily , H Wolosker (2005). D-serine is the dominant endogenous coagonist for NMDA receptor neurotoxicity in organotypic hippocampal slices. Journal of Neuroscience 25, 9413–9417.
G Tsai , P Yong , LC Chung , N Lange , (1998). D-serine added to antipsychotics for the treatment of schizophrenia. Biological Psychiatry 44, 1081–1089.
P Tucker , RP Trautman , DB Wyatt , J Thompson , (2007). Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind placebo controlled study. Journal of Clinical Psychiatry 68, 201–206.